GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Senores Pharmaceuticals Ltd

Senores Pharmaceuticals approves Q2 FY27 unaudited financial results

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 29 Oct 2026, 01:52 PM IST  ·  BSE ID: 4145a75a-f8be-465a-ba72-3365ad8aab26
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board reviewed and approved its latest financial performance reports and selected new auditors.
🤖 AI Summary
  • Senores Pharmaceuticals approved un-audited financial results for Q2 FY27 and H1 FY27.
  • Board approved the appointment of joint statutory auditors on Audit Committee recommendation.
  • Statutory auditors Pankaj R. Shah and Associates issued Limited Review Reports.
  • Results cover consolidated and standalone financials for the period ending September 30, 2026.
🏢 How This Affects the Company
💰
Financial Impact
The filing confirms the release of financial results for the period, providing transparency on the company's financial performance to stakeholders.
⚙️
Operational Impact
The appointment of joint statutory auditors is a governance step impacting the audit process for financial reporting.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this board meeting outcome.
👤
Who Is Affected
All shareholders are affected as they receive updated financial information and information regarding the company's audit oversight.
🔍
Management Signal
The board's actions signal adherence to regulatory requirements for timely financial reporting and auditor selection.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Detailed Q2 FY27 financial results with specific figures for revenue and profit.
Announcement of the specific Joint Statutory Auditors and their scope.
Subsequent financial results disclosures for future quarters.
LOW RISK Standard board meeting outcome, no unusual events or significant financial disclosures reported.
💡 Investor Takeaway
Senores Pharmaceuticals disclosed its un-audited financial results for Q2 and H1 FY27 and appointed joint statutory auditors, confirming auditor review.
❓ Frequently Asked Questions
What did Senores Pharmaceuticals' board approve on October 29, 2026?
The board approved the un-audited financial results for the quarter and half-year ended September 30, 2026, and the appointment of joint statutory auditors.
Who are the statutory auditors for Senores Pharmaceuticals for the period ending September 30, 2026?
M/s. Pankaj R. Shah and Associates, Chartered Accountants, have issued their Limited Review Reports on the un-audited financial results.
What financial periods were covered by the Senores Pharmaceuticals board meeting results?
The un-audited financial results covered the quarter and half-year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.